L'Oréal (OR) investor relations material

Financial performance and market context

• Achieved €44 billion in 2025 sales and €6.4 billion net profit, with over 7 billion units sold in more than 150 countries and a market capitalization of €200 billion as of May 2026.

• Outperformed the global beauty market, growing at 4% versus the market's 3.5%, with acceleration in the second half of the year.

• Gross margin reached a record 74.3%, with operating margin improving by 20 basis points despite tariff impacts.

• Proposed dividend increase to €7.20 per share, up 2.9%, with a 56% payout ratio and a 10% loyalty bonus for long-term shareholders.

• Emerging markets contributed 40% of growth, with SAPMENA up 10.9%, Southeast Asia and Middle East at +11%, and Latin America at +8%.

Strategic investments, innovation, and acquisitions

• Invested €1.5 billion in technology, focusing on AI, R&D, and digital transformation, marking a record year for tech investment.

• AI initiatives include consumer journey personalization, marketing optimization, and R&D partnerships (e.g., IBM for molecule discovery).

• Filed 725 patents in 2025, a company record, with a 150bps increase in sales from new launches; named Europe's most innovative company by Fortune Magazine.

• Acquired Kering Beauty (including Creed, Bottega Veneta, Balenciaga, and Gucci licenses) for $4.66 billion, Medik8, Color Wow, and increased stake in Galderma to 20%.

• Expanded into longevity and aesthetics through partnerships, scientific collaborations, and acquisitions, targeting new growth adjacencies.

Category and regional performance

• All divisions and categories grew, with Professional Products Division leading at 7.5%, Dermatological Beauty up 5.5%, and Haircare up 12.9%.

• Hair care and fragrance posted double-digit growth, reinforcing global leadership in these categories.

• All regions posted growth, with U.S. and China accelerating in H2; U.S. grew from +2% to +4%, China from +1% to +5%.

• E-commerce now represents 30% of sales, growing at 13% year-over-year, and is a key driver in emerging markets.

• Skincare faced challenges but rebounded in H2 with innovation and new launches, especially in Dermatological Beauty.